Christian Kuhn

Christian Kuhn

Auto-generated profile, based on publicly available information

Christian Kuhn

Division of Nephrology and Transplantation Medicine, HOCH Cantonal Hospital St.Gallen, St. Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2024 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Open access
PDF file
CKChristian Kuhn
Christian Kuhn
NMNilufar Mohebbi
Nilufar Mohebbi
ARAlexander Ritter
Alexander Ritter
Metabolic acidosis is a frequent complication in non-transplant chronic kidney disease (CKD) and after kidney transplantation. It occurs when net endogenous acid production exceeds net acid excretion. While nephron loss with reduced ammoniagenesis is the main cause of acid retention in non-transplant CKD patients, additional pathophysiological mechanisms are likely inflicted in kidney transplant recipients. Functional tubular damage by calcineurin inhibitors seems to play a key role causing renal tubular acidosis. Notably, experimental and clinical studies over the past decades have provided evidence that metabolic acidosis may not only be a consequence of CKD but also a driver of disease. In metabolic acidosis, activation of hormonal systems and the complement system resulting in fibrosis have been described. Further studies of changes in renal metabolism will likely contribute to a deeper understanding of the pathophysiology of metabolic acidosis in CKD. While alkali supplementation in case of reduced serum bicarbonate < 22 mmol/l has been endorsed by CKD guidelines for many years to slow renal functional decline, among other considerations, beneficial effects and thresholds for treatment have lately been under intense debate. This review article discusses this topic in light of the most recent results of trials assessing the efficacy of dietary and pharmacological interventions in CKD and kidney transplant patients.

2 February 2021 in Transplant International
Verified
Journal Article
Closed access
PDF file
CKChristian Kuhn
Christian Kuhn
BLBrian M. Lang
Brian M. Lang
SLSylvia Lörcher
Sylvia Lörcher
AKAndrea Karolin
Andrea Karolin
IBIsabelle Binet
Isabelle Binet
DSDaniel Sidler
Daniel Sidler
Background Kidney transplantation from older and marginal donors is effective to confront organ shortage. However, limitations after transplantation of kidneys from very marginal kidney donors remain unclear. We compared patient and graft outcome, achieved allograft function and quality of life of renal transplantations from Very Senior Donors (VSD, defined as donors aged 70 years and older) with Senior Donors (SD, aged 60‐70 years) and Regular Donors (RD, aged younger than 60 years) in Switzerland. Methods We evaluated the outcome of 1554 adult recipients of deceased donor kidney transplantations from 05/2008 to 12/2019; median follow‐up was 4.7 years. Failure‐free survival (freedom from graft loss or death), glomerular filtration rate (eGFR) and quality of life at 12 months was analyzed for RD (reference group, n=940), SD (n=404) and VSD (n=210). Results Failure‐free survival decreased with increasing donor age, mainly attributable to premature graft loss. Still, overall 5‐year failure‐free survival reached 83.1%, 81.0% and 64.0% in the RD, SD and VSD subgroups, respectively. eGFR 12 months post‐transplantation was significantly higher in RD compared to SD and VSD. The acceptance rate of donor candidates for kidney TPL was 78% for the entire cohort (87% for RD, 79% for SD and 56% for VSD). Conclusion Deceased donor kidney transplantation from donors aged 70 years or older is associated with an inferior, yet acceptable failure‐free outcome, with sustained quality of life.

6 February 2022 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
CKChristian Kuhn
Christian Kuhn
ABAlex Born
Alex Born
AKAndrea Karolin
Andrea Karolin
BLBrian Lang
Brian Lang
IBIsabelle Binet
Isabelle Binet
TSthe Swiss Transplant Cohort Study
the Swiss Transplant Cohort Study

18 December 2024 in PLOS Digital Health
Verified
Journal Article
Open access
SSSimon Schwab
Simon Schwab
HSHélène Steck
Hélène Steck
IBIsabelle Binet
Isabelle Binet
AEAndreas Elmer
Andreas Elmer
WEWolfgang Ender
Wolfgang Ender
FIFranz Immer
Franz Immer
Deceased-donor kidney allografts are exposed to ischemic injury during ex vivo transport due to the lack of blood oxygen supply. Hypothermic machine perfusion (HMP) effectively reduces the risk of delayed graft function in kidney transplant recipients compared to standard cold storage. However, no free software implementation is available to analyze HMP data for state-of-the-art visualization and quality control. We developed the tool EXAM (ex-vivo allograft monitoring) as an interactive analytics dashboard. We wrote functions in the R programming language to read, process, and analyze HMP data from the LifePort kidney transporter (Organ Recovery Systems, USA). Time series for pressure, flow rate, organ resistance, and temperature are visualized, and relevant statistical indicators have been developed. We explain how data were processed, and indicators were calculated, and we present summary statistics for N = 255 kidney allografts receiving machine perfusion in Switzerland between 2020 and 2023. Median (interdecile range, IDR) of the main indicators were as follows: perfusion duration 5.18 hours (2.29−11.2), flow rate 110 ml/min (52.9−167), ice temperature 1.97°C (1.53−3.07), and perfusate temperature 6.68°C (5.58−8.36). We implemented the dashboard to identify issues, such as atypical perfusion parameters, high ice, or high perfusate temperature to inform transplant centers for quality assurance. In conclusion, EXAM is a free tool that statisticians and data scientists can quickly deploy to enable quality control at transplant organizations that use LifePort kidney transporters. An online viewer is available at https://data.swisstransplant.org/exam/.

6 February 2025 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
CKChristian Kuhn
Christian Kuhn
BJBernd Jänigen
Bernd Jänigen
LMLaura Matuschik
Laura Matuschik
MRMax J. Rieger
Max J. Rieger
DSDaniel Sidler
Daniel Sidler
SZStefan Zschiedrich
Stefan Zschiedrich
Despite advances in kidney transplant surgery and immunosuppression, lymphoceles remain a frequent complication in the early postoperative period following kidney transplantation, often requiring reintervention. While long-term outcomes such as patient and allograft survival are well studied, the impact of lymphocele formation on mid-term allograft function remains unclear. This multicentric study included 711 recipients of living donor kidney transplants to investigate the impact of lymphocele formation on mid-term graft function. Outcomes assessed included estimated glomerular filtration rate (eGFR) at 12 months, eGFR slope, and both patient and allograft survival. Lymphoceles were detected in 17.4% of the recipients, with a median volume of 129 ml, and 71.8% of these patients required intervention. Patients without lymphocele formation had a significantly higher median eGFR at 12 months (52.1 ml/min/1.73 m²) compared to those with lymphoceles (48.7 ml/min/1.73 m²). Additionally, patients with lymphocele formation demonstrated a steeper median eGFR slope (-2.3 ml/min/1.73 m²/year) than those without (-0.3 ml/min/1.73 m²/year). No significant difference was observed in the composite outcome of allograft survival and patient death between the two groups. Lymphocele formation after living donor kidney transplantation is associated with a steeper decline in graft function. They may reflect a disturbed microvasculature and warrant closer control of cardiovascular risk factors and allograft monitoring of affected patients. Not applicable, the study is not a clinical trial.

1 January 2026
Verified
Journal Article
Closed access
NMNicole Maurer
Nicole Maurer
KLKatrin Ledergerber
Katrin Ledergerber
BDBarbara Denecke
Barbara Denecke
CKChristian Kuhn
Christian Kuhn